Use of Acthar in Rheumatoid Arthritis Related Flares
Who is this study for? Adults with rheumatoid arthritis
What treatments are being studied? Acthar
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
This is a Rheumatoid Arthritis (RA) study. The purpose of this research study is to determine in RA flare, whether musculoskeletal ultrasound (MSUS) inflammatory scores and/or disease activity scores improve with Acthar treatment.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patient must meet 1987 ACR criteria
• Age \> 18 years of age
• Baseline DAS28/Erythrocyte Sedimentation Rate (ESR) \>=3.2
• Stable concomitant Disease Modifying Anti-Rheumatic Drugs (DMARDs)
• Stable prednisone \<10mg or equivalent
• Power Doppler score of \>=10
Locations
United States
California
UCLA David Geffen School of Medicine, Division of Rheumatology
RECRUITING
Los Angeles
Contact Information
Primary
Veena K Rangantah, M.D., M.S.
vranganath@mednet.ucla.edu
310-825-3061
Backup
Bal-lan Yen
byen@mednet.ucla.edu
310-206-4112
Time Frame
Start Date: 2017-07-20
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 40
Treatments
Active_comparator: 40 Units
40 units of Acthar per week
Active_comparator: 80 Units
80 units of Acthar twice per week
Related Therapeutic Areas
Sponsors
Leads: Veena Ranganath, MD, MS